Bictegravir Sodium

ATC — · 3 markets · 5 records

Bictegravir Sodium 3 markets · 5 records Forms
Filters
MarketAU 2FR 2SG 1
Kind

AU 2 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 52.45 mgtablet CombinationBictegravir Sodium 52.45 mg + Emtricitabine 200 mg + Tenofovir Alafenamide Fumarate 28.04 mgBIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets blister packBIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle unknown

FR 2 records · 0 shown of 0 Source Base de données publique des médic · Data as of 2026-11-03 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名BIKTARVY 30 mg/120 mg/15 mg, comprimé pelliculé ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Combination products containing this ingredient

  • 50 mgtablet CombinationBictegravir Sodium 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide Fumarate 25 mgBiktarvy
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.